Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Veterinary Anti-infectives Market Size Changed, over the years?

In recent times, the veterinary anti-infectives market has seen significant growth. The market’s size is predicted to increase from $5.54 billion in 2024 to $6.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. This growth observed in the historic period can be credited to factors such as the rise in pet ownership, the prevalence of infectious diseases, advancements in veterinary medicine, heightened awareness, and government initiatives.

How Much Will the Veterinary Anti-infectives Market Be Worth in 2029?

Anticipations show a vigorous expansion in the veterinary anti-infectives market over the coming years, reaching $8.74 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. This predicted growth within the forecast period is due to factors such as the rising pet population, the emergence of zoonotic diseases, an increase in global pet trade, and escalating veterinary healthcare expenses. The anticipated trends for this period include technological progression, elevated usage of biologicals, the inclusion of telehealth in veterinary services, emphasis on organic and herbal alternatives, the growth of e-commerce in veterinary pharmaceuticals, and strategic collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which is the Largest Company in the Veterinary Anti-infectives Market?

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

What Are the Main Market Drivers in the Veterinary Anti-infectives Industry?

The veterinary anti-infectives market is anticipated to expand due to an expected rise in pet ownership. This refers to keeping a dog, cat, or any other domesticated pet at home. An influx in people adopting pets is apparent as more of the young generation is starting to consider them as family members. Pets are being taken in due to their loyalty, resilience, and their ability to help alleviate feelings of solitude. To highlight, in 2022, Animal Medicines Australia, a non-governmental organization based in Australia, reported a noticeable increase in pet ownership in Australia. The figures showed a rise to 28,730.8 pet owners in 2022, a substantial improvement from the 39% reported in 2021. This substantial 24% increase points to a robust rising trend in pet adoption and care-related investments. This growth in pet ownership indicates a swelling affinity towards pets in Australian homes, thereby boosting the demand for the veterinary anti-infectives market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

How Is the Veterinary Anti-infectives Market Segments Structured?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

What Strategic Trends Are Transforming the Veterinary Anti-infectives Market?

The growing popularity of technological advancements is a notable trend in the veterinary anti-infectives market. Industry-leading companies are leveraging state-of-the-art technologies to maintain their market stronghold. For instance, in February 2022, Elanco Animal Health Incorporated, a company based in the US that specializes in the production of medications and vaccines for pets and livestock, unveiled Increxxa. This newly approved drug combats livestock respiratory disease. It’s delivered via injection to the livestock and swiftly targets the lungs’ infection point. Its main component – tulathromycin, coupled with its quick action and extended half-life, grants the cattle ample time to build robust defenses. This drug, designed for veterinary purposes, uses its active ingredient, tulathromycin, to mitigate the adverse effects of bovine respiratory disease.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Which Global Regions Offer the Highest Growth in the Veterinary Anti-infectives Market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

This Report Delivers Insight On:

1. How big is the veterinary anti-infectives market, and how is it changing globally?

2. Who are the major companies in the veterinary anti-infectives market, and how are they performing?

3. What are the key opportunities and risks in the veterinary anti-infectives market right now?

4. Which products or customer segments are growing the most in the veterinary anti-infectives market?

5. What factors are helping or slowing down the growth of the veterinary anti-infectives market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model